Associate Director Quality Professional
Mumbai, India, 400059
Who we are
How you’ll spend your day
- Continuously improve the TAPI cGxP Computerized Systems policies, standards, procedures, tools and training.
- Manage site inspection readiness and support with regards to globally managed Computerized Systems.
- Guide TAPI Sites IT and IT QA on inspections trends, observations, authorities expectations and best practices that can mitigate gaps.
- Deliver training programs to TAPI Computerized systems owners.
- Support sites with any IT related project(s) as required.
- Support sites in with computer systems validation, infrastructure qualification and systems life cycle management, together with any remediation needed.
- Conduct GxP computerized systems gap assessments/evaluations with applicable regulations
- Provide QA IT review and approval on all globally managed Computerized System deliverables.
- For some globally managed Computerized System, provide QA IT review and approval on the System deliverables, and for others, represent site users, as System Business Owner.
Your experience and qualifications
- BE / B.Tech in Information Technology
- 10 to 15 years of experience
Reports To
- Director, IT Quality Compliance
Teva’s Equal Employment Opportunity Commitment
TAPI is the leading international supplier of active pharmaceutical ingredients (APIs). With the industry's broadest portfolio including over 350 API products. We are the go-to global supplier for APIs, supporting 80% of top 50 global pharmaceutical companies. We are proud of our reliable history in the generic API industry dating back over 80 years, and the fact we are considered to be one of the most trusted API suppliers, these enable TAPI to lead the industry, based on our experience, expertise, technologies, and exceptional customer service.
Our employees are at the core of our success. Our Headquartered is in Israel, TAPI employs more than 4,000 professionals at 14 sites worldwide. Our state-of-the-art production facilities are located in Italy, Hungary, the Czech Republic, Croatia, Israel, Mexico and India. Our significant ongoing investment in R&D generates a steady flow of APIs, enabling timely introduction of new products to market.